Literature DB >> 21669487

Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM.

Atsunori Tsuchiya1, Hiroteru Kamimura, Yasushi Tamura, Masaaki Takamura, Satoshi Yamagiwa, Takeshi Suda, Minoru Nomoto, Yutaka Aoyagi.   

Abstract

We analyzed hepatocellular carcinoma (HCC) with progenitor cell features using hepatic stem/progenitor cell marker neural cell adhesion molecule (NCAM). Approximately 8.3% of the operated HCC cases expressed NCAM, and 22.3% of the HCC patients had soluble NCAM levels >1000ng/ml (the "highly soluble" NCAM group). Soluble NCAM status was a significant independent factor predictive of long-term survival in patients with HCC, and high levels of soluble NCAM were significantly related to intrahepatic metastasis. The 140-kDa NCAM isoform was specifically detected in the "highly soluble" NCAM group of HCC patients andits related signals are potential drug targets for NCAM+ HCC.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669487     DOI: 10.1016/j.canlet.2011.05.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis.

Authors:  Shun-ichi Ariizumi; Masakazu Yamamoto
Journal:  Surg Today       Date:  2014-09-25       Impact factor: 2.549

Review 2.  Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers.

Authors:  Regina Cheuk-Lam Lo; Irene Oi-Lin Ng
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

3.  Evaluation of CD133 and CD56/NCAM expression in Wilms tumor and their association with prognostic factors.

Authors:  Amir Hossein Jafarian; Nona Zabolinejad; Nema Mohamadian Roshan; Sara Hashemi; Masoumeh Gharib
Journal:  Iran J Basic Med Sci       Date:  2020-07       Impact factor: 2.699

Review 4.  Pathogenesis, diagnosis, and management of cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  Gastroenterology       Date:  2013-10-15       Impact factor: 22.682

5.  Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells.

Authors:  Vincenzo Desiderio; Petros Papagerakis; Virginia Tirino; Li Zheng; Margarite Matossian; Mark E Prince; Francesca Paino; Luigi Mele; Federica Papaccio; Roberta Montella; Gianpaolo Papaccio; Silvana Papagerakis
Journal:  Oncotarget       Date:  2015-01-01

6.  Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy.

Authors:  Jun Liu; Ping Hua; Li Hui; Li-Li Zhang; Zhen Hu; Ying-Wei Zhu
Journal:  Exp Ther Med       Date:  2016-08-12       Impact factor: 2.447

7.  Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.

Authors:  Toru Setsu; Atsunori Tsuchiya; Takayuki Watanabe; Takuro Nagoya; Satoshi Ikarashi; Kazunao Hayashi; Junji Yokoyama; Satoshi Yamagiwa; Shuji Terai
Journal:  Case Rep Gastroenterol       Date:  2017-03-21

8.  Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.

Authors:  Smita Mary Matthai; Banumathi Ramakrishna
Journal:  Indian J Med Res       Date:  2015-10       Impact factor: 2.375

9.  Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma.

Authors:  Jong Jin Sung; Sang Jae Noh; Jun Sang Bae; Ho Sung Park; Kyu Yun Jang; Myoung Ja Chung; Woo Sung Moon
Journal:  J Pathol Transl Med       Date:  2015-11-18

10.  Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers.

Authors:  Satoshi Seino; Atsunori Tsuchiya; Yusuke Watanabe; Yuzo Kawata; Yuichi Kojima; Shunzo Ikarashi; Hiroyuki Yanai; Koji Nakamura; Daisuke Kumaki; Masaaki Hirano; Kazuhiro Funakoshi; Takashi Aono; Takeshi Sakai; Jun Sakata; Masaaki Takamura; Hirokazu Kawai; Satoshi Yamagiwa; Toshifumi Wakai; Shuji Terai
Journal:  Oncotarget       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.